2455specific cell type or hiking over terrain from the 'valley' of one lineage directly to that of another -the speakers at this year's Keystone Symposium illuminated the ease by which cellular identity can now be manipulated.Rather than presenting the meeting in chronological order, we have organized our review around several central questions that were collectively addressed at this meeting. These include: 'what is the best method for producing induced pluripotent stem cells (iPSCs) and are they equivalent to embryonic stem (ES) cells?' (Fig. 1); 'what is the provenance of an ES cell and why do human and mouse stem cells have distinct properties?'; 'what are the molecular circuits that control stem cell self-renewal and differentiation?'; 'how do these circuits integrate signals from injured or aging tissues?'; and, finally, 'can we control stem cell differentiation to allow the preparation of therapeutically relevant cell types with real utility?'.A gondola back to the summit or to a distinct peak? A central topic of this year's meeting was whether iPSCs are equivalent to ES cells and whether the methods used for reprogramming dramatically alter the resulting stem cells. Both Yamanaka and James Thomson (University of Wisconsin, WI, USA) touched on this issue in their keynote addresses. Thomson shared a perspective on their approach for generating iPSCs and described a collaboration with Shuchin Zhang (University of Wisconsin, WI, USA) in which they determined whether these pluripotent cells could be differentiated into motor neurons (Hu et al., 2010). This provocative talk suggested that a fundamental deficit exists in the ability of human iPSCs to differentiate: several iPSC lines failed to generate motor neurons at the efficiency exhibited by ES cell lines, even when they lacked transgenic insertions (Hu et al., 2010).The theme of abnormal iPSC differentiation continued in Yamanaka's talk. He described attempts to differentiate mouse iPSCs into secondary neurospheres (Miura et al., 2009). When this experiment was performed with iPSCs that carried a Nanog::GFP reporter, in some lines, the reporter of pluripotency failed to be extinguished (Miura et al., 2009). Intriguingly, reporter expression was not uniform across all cells but, rather, was restricted to what Yamanaka labeled as 'unsafe' cells within the line. When cell lines were subcloned and expanded, they gave rise to heterogeneous populations of either 'safe' or 'unsafe' iPSCs. These 'unsafe' cells were more likely to generate a teratoma after transplantation into the mouse brain (Miura et al., 2009). The difference between the safe and unsafe populations remains to be determined.Christoph Bock (Harvard University, MA, USA) from Alex Meissner's group continued with this theme and described a collaboration between four groups -Alex Meissner's, Kevin Eggan's (Harvard University, MA, USA), Hynek Wichterle's and Chris Henderson's (both at Columbia University, NY, USA) -to determine the variation in the properties of human iPSCs and ES cells. The goal was...